About Anhui Anke Biotechnology
Anhui Anke Biotechnology is a publicly listed company based in Hefei (China) founded in 1993. Biomedicine research, development, production, and sales are conducted. The company has 2,650 employees. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Enterprise business is the research and development, production, and sales of biomedicine. It has a nationally recognized enterprise technology center, a national and local joint engineering research center for precision tumor therapy technologies and products, an Anhui bioengineering laboratory, an Anhui key laboratory for genetic engineering pharmaceuticals, and an Anhui precision tumor therapy product innovation center.
- Headquarters Hefei, China
- Employees 2,650
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website ankebio.com
- Legal Name Anhui Anke Biotechnology (Group) Co., Ltd. Class A
- Annual Revenue$375.66 M (USD)4.36as on Dec 31, 2025
- Net Profit$105.01 M (USD)4as on Dec 31, 2025
- EBITDA$130.29 M (USD)5.7as on Dec 31, 2025
- Employee Count2,650
People of Anhui Anke Biotechnology
1 people are tracked at Anhui Anke Biotechnology (1 in leadership); the tracked headcount is 2,650.
| Name | Role | Group |
|---|---|---|
Li Hua Song | CEO | Leadership |
Complete people profiles for Anhui Anke Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Anhui Anke Biotechnology
Anhui Anke Biotechnology is a publicly listed company on the SZSE with ticker symbol 300009 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Oct 2009
- Listed onSZSE: 300009
- Listed entityAnhui Anke Biotechnology (Group) Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100000GY2
- Share price8.16 CNY (-0.85% on the day) · 2026-10-14
- Market capitalisation13,749,866,866.00 CNY
- Price to earnings19.3
- EPS (diluted, trailing year)0.42 CNY
- Dividend yield3.04%
- Volume (last session)14,125,879
Financials of Anhui Anke Biotechnology
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.63B CNY | 735.2M CNY | 912.2M CNY |
| 2024 | 2.52B CNY | 707.0M CNY | 863.0M CNY |
| 2023 | 2.85B CNY | 847.2M CNY | 1.01B CNY |
| 2022 | 2.32B CNY | 703.3M CNY | 872.0M CNY |
| 2021 | 2.16B CNY | 206.6M CNY | 676.4M CNY |
Detailed financial statements for Anhui Anke Biotechnology
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Anhui Anke Biotechnology
The website of Anhui Anke Biotechnology (ankebio.com) receives about 1.2K visits a month and ranks #1,166,402 among all websites worldwide, #1,458 in Biotechnology and Pharmaceuticals.
- Monthly visits1.2K
▼ 79.1% vs previous month
- Unique visitors1.2K
per month
- Global rank#1,166,402
among all websites
- Category rank#1,458
Health · Biotechnology and Pharmaceuticals
- Bounce rate23%
- Pages per visit46.9
- Average visit15 min 41 sec
- DevicesDesktop 85% · Mobile 15%
Websites whose visitors overlap most with Anhui Anke Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ligand.com | 100% | 7K | #3,254,882 | View details | |
| aphios.com | 100% | 2.3K | #6,635,872 | View details | |
| sciclone.com | 100% | View details | |||
| sinobiopharm.com | 100% | 11.7K | #2,827,230 | View details | |
| afnm.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Anhui Anke Biotechnology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Anhui Anke Biotechnology
Complete news archive for Anhui Anke Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anhui Anke Biotechnology
Anhui Anke Biotechnology was founded in 1993.
Anhui Anke Biotechnology is headquartered in Hefei, China. It is registered at Hefei, Anhui, China.
Anhui Anke Biotechnology has 2,650 employees.
Annual revenue of Anhui Anke Biotechnology is $375.66M as on Dec 31, 2025.
Enterprise business is the research and development, production, and sales of biomedicine. It has a nationally recognized enterprise technology center, a national and local joint engineering research center for precision tumor therapy technologies and products, an Anhui bioengineering laboratory, an Anhui key laboratory for genetic engineering pharmaceuticals, and an Anhui precision tumor therapy product innovation center.
Yes, Anhui Anke Biotechnology is publicly traded on SZSE under the ticker symbol 300009.